Morepen Laboratories Ltd Share Price
(MOREPENLAB)
₹50.24▲3.25%
as on 04:02PM, 21 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.59 % |
3 Month Return | -36.17 % |
1 Year Return | + 16.57 % |
Market Stats | |
Previous Close | ₹48.66 |
Open | ₹49.19 |
Volume | 74.28L |
Upper Circuit | ₹58.39 |
Lower Circuit | ₹38.92 |
Market Cap | ₹2,752.92Cr |
P/E Ratio
21.02
PEG Ratio
23.62
Market Cap
₹2,752.92 Cr
P/B Ratio
2.42
EPS
1.89
Dividend Yield
0Sector
Pharmaceuticals
ROE
13.29
Morepen Labs Launches Affordable Diabetes Treatment - 17 Mar, 2025
Morepen Laboratories Launches Online Pharmacy Subsidiary - 19 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, MOREPENLAB stock has moved up by 17.3%
Revenue Rich
Revenue is up for the last 2 quarters, 442.71 Cr → 458.12 Cr (in ₹), with an average increase of 3.4% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 2.08% to 2.22% in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 69.0% return, outperforming this stock by 52.4%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.4% return, outperforming this stock by 108.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Dec 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 60.56% to 60.47% in Dec 2024 quarter
Profit Down
Netprofit is down for the last 3 quarters, 36.17 Cr → 26.69 Cr (in ₹), with an average decrease of 13.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 35.65% | 0.00 | |
Foreign Institutions | 2.22% | 6.96 | |
Mutual Funds | 0% | 33.33 | |
Retail Investors | 60.47% | ||
Others | 1.65% |
Morepen Laboratories in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (21.02x)
March 21, 2025
Industry (53.16x)
March 21, 2025
Highest (64.70x)
January 22, 2018
Morepen Laboratories Ltd’s net profit fell -16.57% since last year same period to ₹26.69Cr in the Q3 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -23.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Neutral trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,752.92 Cr | 111.35% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
NA | ₹264.97 Cr | 128.74% | 0.50 | NA | NA | |
NA | ₹35.03 Cr | 160.09% | 0.53 | NA | NA | |
NA | ₹44.75 Cr | 99.16% | 0.81 | NA | NA | |
NA | ₹789.51 Cr | 259.33% | 0.91 | ₹55 Cr | ₹575 Cr |
Organisation | Morepen Laboratories |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Morepen Laboratories Ltd share price today stands at ₹50.24, Open: ₹49.19, Previous Close: ₹48.66, High: ₹50.8, Low: ₹48.67, 52 Week High: ₹100.9, 52 Week Low: ₹40.2.
Today's traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 74.28L.
Today's market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹2752.92Cr.
Morepen Laboratories Ltd (MOREPENLAB) share price is ₹50.24. It is down -50.21% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd (MOREPENLAB) share price is ₹50.24. It is up 24.98% from its 52 Week Low price of ₹40.2